• Marinkovic, Jelena
• Trifunovic, Danijela
• Vukcevic, Vladan
• Dikic, Ana Djordjevic
• Juricic, Stefan
• Beleslin, Branko
• Ostojic, Miodrag
• Ristic, Arsen
• Stojkovic, Sinisa
• Giga, Vojislav
• Orlic, Dejan
• Dobric, Milan
• Boskovic, Nikola
• Tesic, Milorad
• Stankovic, Goran
• Jovanovic, Ivana
• Petrovic, Olga
• Aleksandric, Srdjan
• Tomasevic, Miloje

Abstract

<jats:sec xml:lang="en"><jats:title>Background</jats:title><jats:p xml:lang="en">Microvascular dysfunction might be a major determinant of clinical deterioration and outcome in patients with hypertrophic cardiomyopathy (HCM). However, long‐term prognostic value of transthoracic Doppler echocardiography (TDE) coronary flow velocity reserve (CFVR) on clinical outcome is uncertain in HCM patients. Therefore, the aim of our study was to assess long‐term prognostic value of CFVR on clinical outcome in HCM population.</jats:p></jats:sec><jats:sec xml:lang="en"><jats:title>Methods and Results</jats:title><jats:p xml:lang="en">We prospectively included 150 HCM patients (82 women; mean age 48±15 years). Patients’ clinical characteristics, echocardiographic and CFVR findings (both for left anterior descending [LAD] and posterior descending artery [PD]), were assessed in all patients. The primary outcome was a composite of: HCM related death, heart failure requiring hospitalization, sustained ventricular tachycardia and ischemic stroke. Patients were stratified into 2 subgroups depending on CFVR LAD value: Group 1 (CFVR LAD&gt;2, [n=87]) and Group 2 (CFVR LAD≤2, [n=63]). During a median follow‐up of 88 months, 41/150 (27.3%) patients had adverse cardiac events. In Group 1, there were 8/87 (9.2%), whereas in Group 2 there were 33/63 (52.4%,<jats:italic>P</jats:italic>&lt;0.001 vs. Group 1) adverse cardiac events. By Kaplan‐Meier analysis, patients with preserved CFVR LAD had significantly higher cumulative event‐free survival rate compared to patients with impaired CFVR LAD (96.4% and 90.9% versus 66.9% and 40.0%, at 5 and 8 years, respectively: log‐rank 37.2,<jats:italic>P</jats:italic>&lt;0.001). Multivariable analysis identified only CFVR LAD≤2 as an independent predictor for adverse cardiac outcome (HR 6.54; 95% CI 2.83–16.30,<jats:italic>P</jats:italic>&lt;0.001), while CFVR PD was not significantly associated with outcome.</jats:p></jats:sec><jats:sec xml:lang="en"><jats:title>Conclusions</jats:title><jats:p xml:lang="en">In patients with HCM, impaired CFVR LAD (≤2) is a strong, independent predictor of adverse cardiac outcome. When the aim of testing is HCM risk stratification and CFVR LAD data are available, the evaluation of CFVR PD is redundant.</jats:p></jats:sec>

Topics

• impedance spectroscopy
• composite
• size-exclusion chromatography
• chemical ionisation